E Fund Management Co., Ltd. - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 132 filers reported holding CTI BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
E Fund Management Co., Ltd. ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$271
-41.5%
64,520
-16.3%
0.02%
-47.4%
Q4 2022$463
-99.9%
77,101
+2.6%
0.04%
-7.3%
Q3 2022$437,000
+45.7%
75,133
+49.8%
0.04%
+51.9%
Q2 2022$300,000–50,171–0.03%–
 Download
Other shareholders

There were no reported owners of CTI BIOPHARMA CORP in Q3 2022.

NameSharesValueWeighting ↓
View complete list of CTI BIOPHARMA CORP shareholders